چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده ثبت کننده مقاله | یاسین احمدی |
| مرحله جاری مقاله | تایید نهایی |
| دانشکده/مرکز مربوطه | کمیته تحقیقات دانشجویی |
| کد مقاله | 60960 |
| عنوان فارسی مقاله | تعادل بین القا و مهار مسیر موالونات, سرکوب سرطان بوسیله استاتینها را تنظیم می کند: مروری بر مکانیسم های مولکولی |
| عنوان لاتین مقاله | The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms |
| ناشر | 3 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ | خیر |
| عنوان نشریه (خارج از لیست فوق) | |
| نوع مقاله | Review Article |
| نحوه ایندکس شدن مقاله | ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت | https://www.sciencedirect.com/science/article/pii/S0009279717303782?via%3Dihub |
| Statins are widely used drugs for their role in decreasing cholesterol in hypercholesterolemic patients. Statins through inhibition of Hydroxy Methyl Glutaryl-CoA Reductase (HMGCR), the main enzyme of the cholesterol biosynthesis pathway, inhibit mevalonate pathway that provides isoprenoids for prenylation of different proteins such as Ras superfamily which has an essential role in cancer developing. Inhibition of the mevalonate/isoprenoid pathway is the cause of the cholesterol independent effects of statins or pleotropic effects. Depending on their penetrance into the extra-hepatic cells, statins have different effects on mevalonate/isoprenoid pathway. Lipophilic statins diffuse into all cells and hydrophilic ones use a variety of membrane transporters to gain access to cells other than hepatocytes. It has been suggested that the lower accessibility of statins for extra-hepatic tissues may result in the compensatory induction of mevalonate/isoprenoid pathway and so cancer developing. However, most of the population-based studies have demonstrated that statins have no effect on cancer developing, even decrease the risk of different types of cancer. In this review we focus on the cancer developing “potentials” and the anti-cancer “activities” of statins regarding the effects of statins on mevalonate/isoprenoid pathway in the liver and extra-hepatic tissues. |
| نویسنده | نفر چندم مقاله |
|---|---|
| یاسین احمدی | اول |
| امیر قربانی حق جو | دوم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| 1-s2.0-S0009279717303782-main.pdf | 1396/11/23 | 1262099 | دانلود |
| Home Page.gif | 1396/11/27 | 191834 | دانلود |
| IF Page.tif | 1396/11/27 | 116472 | دانلود |
